FOR IMMEDIATE RELEASE: Mind Genomics Advisors, Inc. Announces its New Identity as Rehavior, Inc.
"Leading Behavioral Science Firm Rebrands to Better Reflect Its Focus on Improving Patient Engagement and Clinical Outcomes" Saratoga Springs, NY, March 02, 2023.
Mind Genomics Advisors, Inc. today announced it has changed its name to Rehavior, Inc. The new name reflects the company's dedication to enhancing patient engagement in the healthcare sector through the application of behavioral science at scale.
Rehavior specializes in tailoring healthcare communications to positively influence patient behavior and decision-making. The company's flagship product, the Health Motivation Identifier (HMI), provides healthcare organizations with the personalized messaging strategies needed to effectively engage patients and drive positive outcomes. Deeply grounded in behavioral science, Rehavior’s proprietary solutions offer healthcare providers with valuable insights into the motivations, both conscious and subconscious, that drive an individual patient’s healthcare choices and decision making.
"At Rehavior, our mission is to rearrange, redirect, and reengage the way healthcare providers communicate with patients," said Ken Rotondo, President at Rehavior. "Our new name embodies this mission and underscores our commitment to improving patient outcomes through behavioral science," said Tim Feldman, CEO at Rehavior.
For more information, please contact Elizabeth Burke at eburke@rehavior.com or by calling (877) 446-6886.
Rehavior is an elite behavioral science organization that works to enhance patient engagement and compliance in healthcare. The company partners with leading healthcare organizations and provides them with easily integrated tools, such as the Health Motivation Identifier (HMI), to ensure medical staff have real-time access to the precise messages and communication styles needed to drive positive patient outcomes. Rehavior's mission is to revolutionize the healthcare industry by applying behavioral science at scale.